Phone: (516) 487-8207
Across the country in studies at University medical centers, doctors were using experimental brain stents to try and prevent strokes. A stent is a small mesh-like device placed into a vein or artery that is obstructed with plaque. They're designed to keep open the vein or artery.
These specific brain stents were designed to prevent narrowing of small vessels in the brain which can cause small strokes, known as TIA's or transient ischemic attacks.
According to Newsday, recent findings indicate there were a high number of strokes and deaths among patients who received this experimental stent.
Out of 451 patients in the experimental trial, half received the experimental device and half received medication. 15% of those suffered stroke within the first 30 days. Five died. Of the patients who instead received medicine, 5.8% of those on blood thinners and aspirin had a recurrent stroke and only one died.
The stent, developed by Boston Scientific was apparently approved by the Feds as a humanitarian exemption for people who experience a stroke and failed drug therapy. A drug exemption is based on hopeful but limited data that does not require the drug company to provide extended research on patients who have actually used it.
_____________
What does this mean if you suffered stroke or your loved one died as a result of this experimental stent? Does that mean you might have a valid claim against the drug manufacturer?
You might, but there many unknowns that need to be explored. For example, what type of risks were you told about? Was it explained to you that this was an experimental study fraught with risks and a limited database of patients who had tested the device?
To learn more about how these types of cases were, I encourage you to explore my educational website. If you have legal questions about your particular matter, pick up the phone and call me at 516-487-8207 or by e-mail at lawmed10@yahoo.com. I welcome your call.
Read More About Feds Pull Plug on Anti-Stroke Brain Stent as a Treatment Tool...
